240 related articles for article (PubMed ID: 22166496)
1. The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes.
Teo MT; Landi D; Taylor CF; Elliott F; Vaslin L; Cox DG; Hall J; Landi S; Bishop DT; Kiltie AE
Carcinogenesis; 2012 Mar; 33(3):581-6. PubMed ID: 22166496
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-binding site polymorphisms in genes involved in colorectal cancer etiopathogenesis and their impact on disease prognosis.
Schneiderova M; Naccarati A; Pardini B; Rosa F; Gaetano CD; Jiraskova K; Opattova A; Levy M; Veskrna K; Veskrnova V; Buchler T; Landi S; Vodicka P; Vymetalkova V
Mutagenesis; 2017 Oct; 32(5):533-542. PubMed ID: 29048575
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx.
Zhu L; Sturgis EM; Zhang H; Lu Z; Tao Y; Wei Q; Li G
Int J Cancer; 2017 Oct; 141(7):1355-1364. PubMed ID: 28646528
[TBL] [Abstract][Full Text] [Related]
4. Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3'-untranslated region of ErbB4 in breast cancer.
Bagheri F; Mesrian Tanha H; Mojtabavi Naeini M; Ghaedi K; Azadeh M
Mol Med Rep; 2016 May; 13(5):4494-8. PubMed ID: 27035115
[TBL] [Abstract][Full Text] [Related]
5. A microRNA-7 binding site polymorphism in HOXB5 leads to differential gene expression in bladder cancer.
Luo J; Cai Q; Wang W; Huang H; Zeng H; He W; Deng W; Yu H; Chan E; Ng CF; Huang J; Lin T
PLoS One; 2012; 7(6):e40127. PubMed ID: 22768238
[TBL] [Abstract][Full Text] [Related]
6. A genetic variation in microRNA target site of KRT81 gene is associated with survival in early-stage non-small-cell lung cancer.
Lee SY; Choi JE; Jeon HS; Hong MJ; Choi YY; Kang HG; Yoo SS; Lee EB; Jeong JY; Lee WK; Lee J; Cha SI; Kim CH; Kim YT; Jheon S; Son JW; Park JY
Ann Oncol; 2015 Jun; 26(6):1142-1148. PubMed ID: 25716425
[TBL] [Abstract][Full Text] [Related]
7. Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.
Gu J; Zhao H; Dinney CP; Zhu Y; Leibovici D; Bermejo CE; Grossman HB; Wu X
Clin Cancer Res; 2005 Feb; 11(4):1408-15. PubMed ID: 15746040
[TBL] [Abstract][Full Text] [Related]
8. A variant at a potentially functional microRNA-binding site in BRIP1 was associated with risk of squamous cell carcinoma of the head and neck.
Liu H; Gao F; Dahlstrom KR; Li G; Sturgis EM; Zevallos JP; Wei Q; Liu Z
Tumour Biol; 2016 Jun; 37(6):8057-66. PubMed ID: 26711789
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer.
Landi D; Gemignani F; Naccarati A; Pardini B; Vodicka P; Vodickova L; Novotny J; Försti A; Hemminki K; Canzian F; Landi S
Carcinogenesis; 2008 Mar; 29(3):579-84. PubMed ID: 18192692
[TBL] [Abstract][Full Text] [Related]
10. Genetic Variations in the 3'-untranslated Regions of Genes Involved in the Cell Cycle and Apoptosis Pathways Affect Bladder Cancer Risk.
Zhang Q; Wang W; Xu W; Du` M; Ma G; Liu H; Chu H; Tong NA; Wang M; Shao J; Zhang Z; Yuan L; Qian J
Cancer Genomics Proteomics; 2018; 15(1):67-72. PubMed ID: 29275364
[TBL] [Abstract][Full Text] [Related]
11. Germline variants of base excision repair genes and breast cancer: A polymorphism in DNA polymerase gamma modifies gene expression and breast cancer risk.
Popanda O; Seibold P; Nikolov I; Oakes CC; Burwinkel B; Hausmann S; Flesch-Janys D; Plass C; Chang-Claude J; Schmezer P
Int J Cancer; 2013 Jan; 132(1):55-62. PubMed ID: 22684821
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of miRNA-binding-site SNPs of MRE11A, NBS1, RAD51 and RAD52 involved in HRR pathway genes and risk of breast cancer in China.
Wu Z; Wang P; Song C; Wang K; Yan R; Li J; Dai L
Mol Genet Genomics; 2015 Jun; 290(3):1141-53. PubMed ID: 25566853
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk.
Figueroa JD; Malats N; Rothman N; Real FX; Silverman D; Kogevinas M; Chanock S; Yeager M; Welch R; Dosemeci M; Tardón A; Serra C; Carrato A; García-Closas R; Castaño-Vinyals G; García-Closas M
Carcinogenesis; 2007 Aug; 28(8):1788-93. PubMed ID: 17557904
[TBL] [Abstract][Full Text] [Related]
14. Variation within 3'-UTRs of base excision repair genes and response to therapy in colorectal cancer patients: A potential modulation of microRNAs binding.
Pardini B; Rosa F; Barone E; Di Gaetano C; Slyskova J; Novotny J; Levy M; Garritano S; Vodickova L; Buchler T; Gemignani F; Landi S; Vodicka P; Naccarati A
Clin Cancer Res; 2013 Nov; 19(21):6044-56. PubMed ID: 24036853
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation in the base excision repair pathway and bladder cancer risk.
Figueroa JD; Malats N; Real FX; Silverman D; Kogevinas M; Chanock S; Welch R; Dosemeci M; Tardón A; Serra C; Carrato A; García-Closas R; Castaño-Vinyals G; Rothman N; García-Closas M
Hum Genet; 2007 Apr; 121(2):233-42. PubMed ID: 17203305
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51.
Silva SN; Tomar M; Paulo C; Gomes BC; Azevedo AP; Teixeira V; Pina JE; Rueff J; Gaspar JF
Cancer Epidemiol; 2010 Feb; 34(1):85-92. PubMed ID: 20004634
[TBL] [Abstract][Full Text] [Related]
17. 172G>T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant.
Lu J; Wang LE; Xiong P; Sturgis EM; Spitz MR; Wei Q
Carcinogenesis; 2007 May; 28(5):988-94. PubMed ID: 17118968
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in poly (ADP-ribose) polymerase-1 (PARP1) promoter and 3' untranslated region and their association with PARP1 expression in breast cancer patients.
Zhai L; Li S; Li H; Zheng Y; Lang R; Fan Y; Gu F; Guo X; Zhang X; Fu L
Int J Clin Exp Pathol; 2015; 8(6):7059-71. PubMed ID: 26261599
[TBL] [Abstract][Full Text] [Related]
19. Double-strand break repair and colorectal cancer: gene variants within 3' UTRs and microRNAs binding as modulators of cancer risk and clinical outcome.
Naccarati A; Rosa F; Vymetalkova V; Barone E; Jiraskova K; Di Gaetano C; Novotny J; Levy M; Vodickova L; Gemignani F; Buchler T; Landi S; Vodicka P; Pardini B
Oncotarget; 2016 Apr; 7(17):23156-69. PubMed ID: 26735576
[TBL] [Abstract][Full Text] [Related]
20. Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility.
Nicoloso MS; Sun H; Spizzo R; Kim H; Wickramasinghe P; Shimizu M; Wojcik SE; Ferdin J; Kunej T; Xiao L; Manoukian S; Secreto G; Ravagnani F; Wang X; Radice P; Croce CM; Davuluri RV; Calin GA
Cancer Res; 2010 Apr; 70(7):2789-98. PubMed ID: 20332227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
